Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor protein p53 inducible protein 13 (TP53I13) is a human protein encoded by the TP53I13 gene. It is induced by activation of the tumor suppressor p53 and is thought to play a role in the negative regulation of cell cycle progression and response to DNA-damaging stimuli such as UV irradiation and xenobiotics. Functional studies suggest a possible tumor suppressor role, as its overexpression can inhibit tumor cell growth. The protein’s detailed molecular function remains unclear, but it is classified within the DUF3105 family, indicating it is a protein of yet unknown function. Mutations or altered expression of TP53I13 have been associated with rare syndromes and potentially cancer susceptibility, though it is not a classical receptor, enzyme, or transporter[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor protein p53 inducible protein 13 (TP53I13).